---
title: "Cardlytics 2023 年第四季度调整后每股收益为 0.14 美元，超过了 0.12 美元的预估，销售额为 8,916.7 万美元，低于 8,955.1 万美元的预估。"
description: "Cardlytics（纳斯达克股票代码：CDLX）报告了 2023 年第四季度每股盈利为 0.14 美元，超出分析师预期 16.67%。销售额为 8,916.7 万美元，低于预期 0.43%。与去年同期相比，该公司的盈利增长了 148.28%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/109972788.md"
published_at: "2024-03-14T20:13:49.000Z"
---

# Cardlytics 2023 年第四季度调整后每股收益为 0.14 美元，超过了 0.12 美元的预估，销售额为 8,916.7 万美元，低于 8,955.1 万美元的预估。

> Cardlytics（纳斯达克股票代码：CDLX）报告了 2023 年第四季度每股盈利为 0.14 美元，超出分析师预期 16.67%。销售额为 8,916.7 万美元，低于预期 0.43%。与去年同期相比，该公司的盈利增长了 148.28%。

Cardlytics（纳斯达克股票代码：CDLX）报告的每股季度收益为 0.14 美元，超过了分析师共识预期的 0.12 美元，增长了 16.67%。这比去年同期每股亏损 0.29 美元的情况增长了 148.28%。该公司季度销售额为 8,916.7 万美元，略低于分析师共识预期的 8,955.1 万美元，下降了 0.43%。与去年同期的销售额 8,250.3 万美元相比，增长了 8.08%。

### Related Stocks

- [CDLX.US - Cardlytics](https://longbridge.com/zh-CN/quote/CDLX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Insider Selling: Cardlytics (NASDAQ:CDLX) CFO Sells $10,070.19 in Stock | Cardlytics CFO Alexis Desieno sold 8,607 shares at $1.17 each, totaling $10,070.19, representing a 4.10% decrease in own | [Link](https://longbridge.com/zh-CN/news/271577979.md) |
| Cardlytics CEO Amit Gupta Reports Sale of Common Shares | Amit Gupta, CEO of Cardlytics Inc., reported the sale of common shares of the company. The full filing is available thro | [Link](https://longbridge.com/zh-CN/news/271576526.md) |
| Cardlytics CFO Alexis DeSieno Reports Disposal of Common Shares | Alexis DeSieno, CFO of Cardlytics Inc., reported the disposal of common shares. The full filing is accessible via the pr | [Link](https://longbridge.com/zh-CN/news/271576140.md) |
| Cardlytics CFO Alexis DeSieno Resigns Effective March 2026 | Cardlytics Inc. announced the resignation of CFO Alexis DeSieno, effective by March 6, 2026, or upon the appointment of  | [Link](https://longbridge.com/zh-CN/news/268760623.md) |
| Lane Generational LLC Purchases 170,480 Shares of Cardlytics, Inc. $CDLX | Lane Generational LLC increased its stake in Cardlytics, Inc. (NASDAQ:CDLX) by 28.0% in Q2, acquiring 170,480 shares, br | [Link](https://longbridge.com/zh-CN/news/262915282.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
